OTC Markets OTCQB - Delayed Quote USD

Aurora Spine Corporation (ASAPF)

0.2251
-0.0114
(-4.82%)
As of 9:30:12 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
17,562.7820
17,562.7820
14,520.4360
14,877.3240
10,544.8070
Cost of Revenue
6,928.6210
6,928.6210
6,309.1440
7,067.5960
5,711.2550
Gross Profit
10,634.1610
10,634.1610
8,211.2920
7,809.7280
4,833.5520
Operating Expense
11,308.1420
11,308.1420
9,706.6850
9,153.1360
7,383.9170
Operating Income
-673.9810
-673.9810
-1,495.3930
-1,343.4080
-2,550.3650
Net Non Operating Interest Income Expense
-175.0850
-175.0850
-185.1700
-163.6030
-159.1000
Other Income Expense
-153.5430
-153.5430
--
5.5450
350.1400
Pretax Income
--
-1,002.6090
-1,680.5630
-1,501.4660
-2,359.3250
Net Income Common Stockholders
-1,085.3620
-1,002.6090
-1,680.5630
-1,501.4660
-2,359.3250
Diluted NI Available to Com Stockholders
-1,002.6090
-1,002.6090
-1,680.5630
-1,501.4660
-2,359.3250
Basic EPS
-0.01
-0.01
-0.02
-0.02
-0.04
Diluted EPS
-0.01
-0.01
-0.02
-0.02
-0.04
Basic Average Shares
77,592.4490
77,592.4490
70,669.2040
66,797.2910
58,706.8980
Diluted Average Shares
77,592.4490
77,592.4490
70,669.2040
66,797.2910
58,706.8980
Total Operating Income as Reported
--
--
--
-1,569.3010
-2,709.4650
Total Expenses
18,236.7630
18,236.7630
16,015.8290
16,220.7320
13,095.1720
Net Income from Continuing & Discontinued Operation
-1,002.6090
-1,002.6090
-1,680.5630
-1,501.4660
-2,359.3250
Normalized Income
--
-849.0660
-1,680.5630
-1,439.1760
-2,359.3250
Interest Expense
175.0850
175.0850
185.1700
163.6030
159.1000
Net Interest Income
-175.0850
-175.0850
-185.1700
-163.6030
-159.1000
EBIT
-827.5240
-827.5240
-1,495.3930
-1,337.8630
-2,200.2250
EBITDA
179.9030
179.9030
-446.1960
-469.2730
-1,551.5380
Reconciled Cost of Revenue
6,928.6220
6,928.6220
6,309.1440
7,067.5960
5,711.2550
Reconciled Depreciation
1,007.4260
1,007.4260
1,049.1970
868.5900
648.6870
Net Income from Continuing Operation Net Minority Interest
-1,002.6090
-1,002.6090
-1,680.5630
-1,501.4660
-2,359.3250
Total Unusual Items Excluding Goodwill
-153.5430
-153.5430
0
-62.2900
0
Total Unusual Items
-153.5430
-153.5430
0
-62.2900
0
Normalized EBITDA
333.4460
333.4460
-446.1960
-406.9830
-1,551.5380
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 9/26/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AVHHL AVITA Medical, Inc.
1.4200
+23.48%
 
IRIX IRIDEX Corporation
0.9867
+1.39%
 
AFIB Acutus Medical, Inc.
0.0018
-10.00%
 
BVS Bioventus Inc.
6.73
+0.52%
 
TMCI Treace Medical Concepts, Inc.
5.90
+1.55%
 
BBNX Beta Bionics, Inc.
19.42
+1.78%
 
SSII SS Innovations International, Inc.
4.8000
-20.00%
 
IART Integra LifeSciences Holdings Corporation
13.90
+2.51%
 
STE STERIS plc
242.69
-0.43%
 
MOVE Movano Inc.
0.7333
+12.38%